Tricida Investor Relations Material
Latest events
Q2 2022
Tricida
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tricida Inc
Access all reports
Tricida Inc. is a pharmaceutical company focused on developing therapies for chronic kidney disease (CKD). The company’s lead investigational drug is designed to treat metabolic acidosis, a common complication in patients with CKD, which can lead to disease progression. Tricida aims to address unmet medical needs in the nephrology space by developing therapies that improve kidney health and patient outcomes. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
TCDA
Country
🇺🇸 United States